CPhI Worldwide

Short-Term Reshoring

The second part of the 2021 CPhI Annual Report looks ahead to predict the pharma manufacturing, therapeutic and technology environment in 2030.

Topics • Strategy

CPhI Worldwide Returns to Madrid

Top-Feature

CHEManager International c/o Wiley-VCH GmbH

Comprehensive Insights into Antibody–Drug Conjugates (ADC) for Precision Cancer Therapy

Evonik Industries AG

Safer, Scalable Pharmaceutical Manufacturing with Flow Chemistry

Global Impact Coalition (GIC)

Siemens Joins the Global Impact Coalition

Article

Reshaping Specialty Chemicals Manufacturing

The State of the US Specialty Chemicals Industry

SOCMA's Jenn Klein examines how specialty chemical manufacturers — the invisible backbone behind pharmaceuticals, electronics, agriculture, and energy — are navigating supply chain shifts, policy uncertainty, and constant change while remaining resilient, disciplined, and focused on execution.

Impress PR

Informa Markets

CPhI Worldwide

Short-Term Reshoring

Patient Centricity: The New Nexus for CDMOs

CPhI Worldwide Announces International Advisory Board

CPhI Announces Founding Members of Expert Industry Panel

CPhI, PharmaEvolution to Analyze Pharma Industry in Monthly and Annual Reports